Global Women’s Health Therapeutics Market: Overview
The global market for women’s health therapeutics is a booming segment of the healthcare industry. This is because almost every woman has to deal with some kind of a gynecological disorder at some point in her life. While most gynecological issues can be cured with proper treatment, sometimes they can prove fatal unless diagnosed at the right time. At present, the women’s health therapeutics market has an impressive pipeline of promising molecules in various stages of clinical development. Some such molecules are abaloparatide, ASP1707, AZD4901, elagolix, romosozumab (AMG785), teriparatide, and vaginorm.
For Any Queries Get Solutions With A PDF Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=214
A report by Transparency Market Research segments the global market for women’s health therapeutics on the basis of treatment for conditions such as menopausal disorders, postmenopausal osteoporosis, gynecological cancer, infertility, polycystic ovary syndrome, endometriosis, and birth control. Among them, the menopause related disorders and post menopause osteoporosis segment are slated to contribute the most to the overall revenue in the upcoming years.
Global Women’s Health Therapeutics Market: Trends and Opportunities
The global women’s health therapeutics market has exhibited phenomenal growth in the last decade on account of the rising awareness among both physicians and women about the health issues specific to the female gender. This, coupled with a large number of pharmaceutical companies entering the market has substantially filliped it. However, treatment for women’s disorders is still quite limited due to the lack of safety. Hence, there is ample room for growth in the market, which going forward too will result in more investments on research and development. This would likely usher in more effective novel therapies that would further bolster the market along with the rising instances of women-centric health issues.
Osteoporosis, for example, is a cause for worry among post-menopausal women. The condition is predicted to affect around 20 percent of post-menopausal women. Osteoporosis results in an alarming loss of bone mass and increases risk of bone fractures. A current noticeable trend in the market is the prevalence of hormone therapeutics in the menopause therapeutics market. However, entry of non-hormones therapeutics in the near future is slated to provide stiff competition to the currently marketed drugs, thereby significantly changing the market dynamics. In fact, the non-hormone therapeutics drugs spell opportunity for both new as well as existing players. Further, although branded drugs enjoy a strong market in developed economies, the emergence of generic drugs after expiration of the patented products is expected to drive the market in low and middle income countries.
Global Women’s Health Therapeutics Market: Regional Outlook
Depending upon geography, the global market for women’s health therapeutics can be divided into Asia Pacific, North America, Europe, and the Rest of the World. Among them, North America and Europe hold a substantial share in the global market because of the increasing elderly population and rising thrust on women’s health in the two continents. The rapidly developing countries of Asia Pacific, Latin America, and the Middle East are also forecasted to expand rapidly on account of the rising prevalence of urological disorders and growing awareness about the different treatments for women’s health issues available in the market. Changing lifestyle and efforts by governments to increase awareness about women’s health has also positively impacted the market in the regions.
View exclusive Global strategic Business report : http://www.transparencymarketresearch.com/women-health-therapeutics-market.html
Companies Mentioned in Report
Some of the prominent players in the global women’s health therapeutics market profiled in the report are Abbott Laboratories, Novartis AG, Amgen, Inc., Eli Lilly Company, Bayer AG, F. Hoffmann-La Roche Ltd., Merck & Co., Inc., Novo Nordisk A/S, and Pfizer, Inc.
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Transparency Market Research
90 State Street,
NY - 12207
USA - Canada Toll Free 866-552-3453
ransparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.